Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amandine Landemaine
Observed names:
A Landemaine,
A. Landemaine,
Landemaine, Amandine
Institutions:
Centre Hospitalier Universitaire de Rennes,
Université de Rennes
Observed institutions:
Inserm,
CIC Rennes,
Hôpital Pontchaillou,
Hôpital Paris Saint-Joseph,
Centre Hospitalier Universitaire de Rennes,
Nutrition, métabolismes et cancer,
Université Rennes 1,
Université de Rennes
show all 8
ORCID:
0000-0002-4078-0035
Observed ORCID:
0000-0002-4078-0035
OpenAlex ID:
A5055937144
Predictors of relapse following infliximab de‐escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring
2018
·
Camille Lucidarme
, Antoine Petitcollin
, et al.
·
Alimentary Pharmacology & Therapeutics
·
60
PDF
Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlates With Rate of Infection
2020
·
Amandine Landemaine
, Antoine Petitcollin
, et al.
·
Clinical Gastroenterology and Hepatology
·
37
PDF
Anal Fistulas in Severe Perineal Crohn’s Disease: Mri Assessment in the Determination of Long-Term Healing Rates
2018
·
Charlène Brochard
, Amandine Landemaine
, et al.
·
Inflammatory Bowel Diseases
·
12
A simple clinical score to promote and enhance ferroportin disease screening
2021
·
Amandine Landemaine
, Houda Hamdi-Roze
, et al.
·
Journal of Hepatology
·
10
PDF
OP38 Comparative efficacy of infliximab and vedolizumab after failure of a first anti-TNF in patients with ulcerative colitis: a double-blind randomized controlled trial (EFFICACI)
2025
·
G Bouguen M.D.- PhD.
, M Nachury
, et al.
·
Journal of Crohn s and Colitis
·
6
Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate
2023
·
Nadia Fathallah
, Laurent Siproudhis
, et al.
·
Colorectal Disease
·
6
High‐grade intraepithelial lesions of the anus—patience: A road to wisdom
2025
·
C. Gouriou
, A. Landemaine
, et al.
·
Colorectal Disease
·
3
Tu1907: EVALUATION OF SUBCUTANEAOUS INFLIXIMAB FOR PERIANAL FISTULA HEALING IN CROHN’S DISEASE : PRELIMINARY RESULTS FROM THE REMSILAP MULTICENTER OBSERVATIONAL COHORT STUDY
2025
·
Manon Haas
, Stephanie Hamonic
, et al.
·
Gastroenterology
·
2
Anal neoplasm: Streamline follow-up of low-grade dysplasia
2025
·
Aurore Carlo
, Laurent Siproudhis
, et al.
·
Digestive and Liver Disease
·
1
PDF
Dysfonction mitochondriale au cours de l’inflammation et stimulation du métabolisme énergétique en phase cicatricielle dans un modèle murin de colite chimio-induite
2020
·
Lan, Annaïg
, Magnin, Benoit
, et al.
·
HAL
·
1
Per-endoscopic rectal fistulotomy: A new endoscopic rectal myotomy technique to support the management of complex anorectal fistulas
2026
·
Timothee Wallenhorst
, Maria Parmigiani
, et al.
·
Endoscopy
Infliximab Versus Vedolizumab After Failure of a First Anti-tnf for Moderate-to-severe Ulcerative Colitis: A Double-blind Randomised Controlled Trial
2026
·
Guillaume Bougen
, Xavier Hebuterne
, et al.
·
SSRN Electronic Journal
PDF
Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease
2025
·
David Laharie
, Pauline Rivière
, et al.
·
Clinics and Research in Hepatology and Gastroenterology
912: Comparative Efficacy of Infliximab and Vedolizumab After Failure of a First Anti-tnf in Patients With Ulcerative Colitis: a Double-blind Randomized Controlled Trial (efficaci)
2025
·
Guillaume Bouguen
, Maria Nachury
, et al.
·
Gastroenterology
Su1836 – High Exposure to Infliximab is Associated with Increased Risk of Infections in Patients with Inflammatory Bowel Disease
2019
·
Amandine Landemaine
, Antoine Petitcollin
, et al.
·
Gastroenterology
PDF
A simple clinical and biological score to promote and enhance Ferroportine disease screening.
2017
·
Landemaine, Amandine
, Hamdi-Roze, Houda
, et al.
·
HAL
Show more works
View as search
Works count:
16
Citation count:
138
H-index:
6
I10-index:
4
Year
Topic
Type